ChemoCentryx Stock Forecast NASDAQ:CCXI

Price Target and Analyst Ratings

Most Recent Rating

Canaccord Genuity is very positive about CCXI and gave it a "Buy" rating on July 07, 2021. The price target was set to $79.00.

Last 30 Days

Over the last 30 days, this security got 2 buy, 0 sell, and 0 hold ratings.

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-07-07	Buy	Reiterated by	Canaccord Genuity	$14.47	$79.00
2021-07-06	Hold - Buy	Upgraded by	Stifel Nicolaus	$14.05
2021-05-13	Neutral - Underweight	Reiterated by	JPMorgan Chase & Co.	$9.97	$57.00 → $17.00
2021-05-13	Strong-Buy - Outperform	Reiterated by	Raymond James	$9.97	$120.00 → $51.00
2021-05-13	Outperform - Market Perform	Reiterated by	SVB Leerink	$9.97	$84.00 → $17.00
2021-05-13	Buy - Hold	Reiterated by	Stifel Nicolaus	$9.97	$93.00 → $26.00
2021-05-13	Buy	Target Lowered by	HC Wainwright	$9.97	$101.00 → $28.00
2021-05-12	Overweight - Neutral	Reiterated by	Piper Sandler	$10.05	$80.00 → $25.00
2021-05-07	Buy	Target Lowered by	HC Wainwright	$10.46	$101.00 → $28.00
2021-05-07	Buy - Hold	Downgraded by	Stifel Nicolaus	$10.46
2021-05-07	Neutral - Underweight	Downgraded by	JPMorgan Chase & Co.	$10.46	$57.00 → $17.00
2021-05-07	Outperform - Market Perform	Downgraded by	SVB Leerink	$10.46
2021-05-07	Strong-Buy - Outperform	Downgraded by	Raymond James	$10.46	$120.00 → $51.00
2021-05-06	Overweight - Neutral	Downgraded by	Piper Sandler	$27.49
2021-05-05	Buy	Reiterated by	Canaccord Genuity	$27.49
2021-03-08	Strong-Buy	Target Raised by	Raymond James	$55.29	$119.00 → $120.00
2021-03-08	Buy	Initiated by	Stifel Nicolaus	$55.29	$93.00
2021-03-02	Strong-Buy	Target Raised by	Raymond James	$66.80	$119.00 → $120.00
2021-03-02	Buy	Target Raised by	HC Wainwright	$66.80	$83.00 → $101.00
2021-03-01	Buy	Initiated by	Stifel Nicolaus	$68.40
2021-01-08	Strong-Buy	Target Raised by	Raymond James	$62.78	$100.00 → $119.00
2020-10-29	Overweight	Target Lowered by	Wells Fargo & Company	$49.52	$79.00 → $70.00
2020-10-29	Outperform	Target Raised by	SVB Leerink	$49.52	$75.00 → $84.00
2020-10-29	Overweight	Target Raised by	Piper Sandler	$49.52	$67.00 → $71.00
2020-10-29	Overweight - Neutral	Downgraded by	JPMorgan Chase & Co.	$49.52	$63.00 → $60.00
2020-09-17		Target Raised by	HC Wainwright	$52.57	$73.00 → $85.00
2020-08-12	Outperform	Target Raised by	SVB Leerink	$52.99	$65.00 → $75.00
2020-08-12	Outperform	Target Raised by	SVB Leerink	$52.99	$65.00 → $75.00
2020-08-11	Strong-Buy	Target Raised by	Raymond James	$53.66	$95.00 → $100.00
2020-07-29	Overweight	Target Lowered by	JPMorgan Chase & Co.	$52.65	$64.00 → $61.00
2020-06-16	Buy	Initiated by	BTIG Research	$62.16	$70.00
2020-06-03	Buy	Reiterated by	Canaccord Genuity	$60.58
2020-05-27	Overweight	Initiated by	Wells Fargo & Co	$63.14	$79.00
2020-05-19	Buy	Target Lowered by	Canaccord Genuity	$56.02	$68.00 → $58.00
2020-05-18	Reduce - Overweight	Target Raised by	Piper Sandler	$58.49	$54.00 → $70.00
2020-05-14	Overweight	Target Raised by	JPMorgan Chase & Co.	$52.22	$61.00 → $64.00
2020-05-12	Buy	Target Raised by	Canaccord Genuity	$56.52	$64.00 → $68.00
2020-05-12	Outperform	Target Raised by	SVB Leerink	$56.52	$54.00 → $65.00
2020-05-12	Strong-Buy	Target Raised by	Raymond James	$56.52	$38.00 → $102.00
2020-05-12	Buy	Target Raised by	HC Wainwright	$56.52	$60.00 → $69.00

CCXI Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -4.98% during the next 3 months and, with a 90% probability hold a price between $8.45 and $16.28 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-08-03	$8.88	$13.00	$17.12
2021-08-04	$8.87	$12.99	$17.11
2021-08-05	$8.85	$12.97	$17.09
2021-08-06	$8.84	$12.96	$17.08
2021-08-09	$8.82	$12.94	$17.06
2021-08-10	$8.81	$12.93	$17.05
2021-08-11	$8.79	$12.91	$17.04
2021-08-12	$8.78	$12.90	$17.02
2021-08-13	$8.76	$12.89	$17.01
2021-08-16	$8.75	$12.87	$16.99
2021-08-17	$8.74	$12.86	$16.98
2021-08-18	$8.72	$12.84	$16.96
2021-08-19	$8.71	$12.83	$16.95
2021-08-20	$8.69	$12.81	$16.93
2021-08-23	$8.68	$12.80	$16.92
2021-08-24	$8.66	$12.78	$16.91
2021-08-25	$8.65	$12.77	$16.89
2021-08-26	$8.63	$12.76	$16.88
2021-08-27	$8.62	$12.74	$16.86
2021-08-30	$8.61	$12.73	$16.85
2021-08-31	$8.59	$12.71	$16.83
2021-09-01	$8.58	$12.70	$16.82
2021-09-02	$8.56	$12.68	$16.80
2021-09-03	$8.55	$12.67	$16.79
2021-09-07	$8.53	$12.65	$16.78
2021-09-08	$8.52	$12.64	$16.76
2021-09-09	$8.50	$12.63	$16.75
2021-09-10	$8.49	$12.61	$16.73
2021-09-13	$8.48	$12.60	$16.72
2021-09-14	$8.46	$12.58	$16.70

About ChemoCentryx

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and cancer in the United States. Its lead drug candidates in clinical development include CCX168, which is in Phase II clinical trials for the treatment of orphan and rare diseases; CCX872, which is in Phase I... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!